Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637416 · ClinicalTrials.gov registry record · Phase 4
Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT00637416 is a Phase 4 study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT00637416, a Phase 4 study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will examine whether lansoprazole (Prevacid) and dietary control versus dietary control alone will improve pediatric hoarseness symptoms.
Interventions
- OTHER Placebo
- DRUG Lansoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00637416
The ClinicalTrials.gov registry entry for NCT00637416 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00637416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00637416 about?
NCT00637416 is a clinical study titled "Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness". This study will examine whether lansoprazole (Prevacid) and dietary control versus dietary control alone will improve pediatric hoarseness symptoms.
What is the current status of trial NCT00637416?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2008-03. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00637416?
The interventions under investigation include: Placebo (OTHER), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT00637416?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.